EN
HI
Syncom Formulations (India) share price chart
Syncom Formulations (India) Share Key Metrics
Volume
18.84 L
Market Cap
1264.30 CR
LTQ@LTP
10@13.45
ATP
13.35
Var Margin
19.89 %
Circuit Range
10.76-16.14
Delivery %
55.45 %
Value
2.52 CR
ASM/GSM
No
Market Lot
1
Summary
SYNCOMF stock price is ₹13.45 as of 10 Aug, 2026. The stock intraday movement has stayed between ₹13.11 and ₹13.49, while Syncom Formulations (India) share price 52 week high low is ₹10.21 & ₹18.80.
In terms of trading activity, SYNCOMF share price has recorded a volume of 18,84,367 shares. The Syncom Formulations (India) has a market cap of ₹940000000. The stock’s Average Traded Price (ATP) stands at ₹13.35, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹13.45.
The Syncom Formulations (India) upper circuit limit is ₹16.14 & The Syncom Formulations (India) lower circuit limit is ₹10.76, with a Value of ₹2.52 CR. The Delivery Percentage for the day is 55.45%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Syncom Formulations (India) Fundamentals
P/E Ratio
16.53
P/B Ratio
3.04
Div. Yield
0
Sector P/E
64.26
Sector P/B
3.23
Sec. Div. Yield
0.51
Syncom Formulations (India) Resistance and Support
Pivot 13.35
Resistance
First Resistance
13.59
Second Resistance
13.73
Third Resistance
13.97
Support
First Support
13.21
Second Support
12.97
Third Support
12.83
Syncom Formulations (India) Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 07 2026 | 13.14 | 13.44 | 1.97% | 13.48 | 13.1 |
| Thu Aug 06 2026 | 13.26 | 13.18 | -1.05% | 13.61 | 13.14 |
| Wed Aug 05 2026 | 13.32 | 13.32 | 0.15% | 13.55 | 13.3 |
Syncom Formulations (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-22 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results & Others |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Syncom Formulations (India) News
Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Syncom Formulations announced the resignation of Mr. Vijay Shankarlal Bankda as Managing Director, effective August 11, 2026. The company stated his resignation is voluntary and part of a planned leadership transition.
Aug 08 2026 15:00:38
Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Resignation of Director
Syncom Formulations announced the resignation of Mr. Kedarmal Shankarlal Bankda, Whole-Time Director, effective August 11, 2026. He is also a Founder and Promoter, and his departure is attributed to health, well-being, and succession planning after over five decades of service.
Aug 08 2026 13:16:08
Read More
Syncom Formulations (India) Management
| Name | Position |
|---|---|
| Vaishali Agrawal | Company Secretary & Compliance Officer |
| Vijay Shankarlal Bankda | Managing Director |
Syncom Formulations (India) Similar Stocks
Amrutanjan Health Care Ltd.
521.40
0.00 (0.00%)
Jagsonpal Pharmaceuticals Ltd.
231.21
0.00 (0.00%)
Suraksha Diagnostic Ltd.
249.55
0.00 (0.00%)
GPT Healthcare Ltd.
159.44
0.00 (0.00%)
Q-Line Biotech Ltd.
538.70
0.00 (0.00%)
Unihealth Hospitals Ltd.
774.00
0.00 (0.00%)
Lincoln Pharmaceuticals Ltd.
600.15
0.00 (0.00%)
Laxmi Dental Ltd.
216.08
0.00 (0.00%)
Bajaj Healthcare Ltd.
329.80
0.00 (0.00%)
Syncom Formulations (India) FAQs
The Buying Price of Syncom Formulations (India) share is 13.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Syncom Formulations (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Syncom Formulations (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Syncom Formulations (India) shares is 16.53. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Syncom Formulations (India) shares is 3.04. Useful to assess the stock's value relative to its book value.
To assess Syncom Formulations (India)’s valuation compare Sector P/E, P/B which are 64.26 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Syncom Formulations (India) is 1264.30 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Syncom Formulations (India) share price is 18.80 & 10.21. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Syncom Formulations (India) belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
